The revenue update will weigh more heavily on the stock than this data. Time value of money. I don’t see big players waiting 3 years for 2591 to be commercialised by taking a position now when they can earn money elsewhere
Ann: Phase 2 trial shows significant improvements in Angelman, page-27
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.41 |
Change
0.150(1.22%) |
Mkt cap ! $1.542B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.60 | $12.31 | $979.2K | 78.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 215 | $12.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.41 | 258 | 2 |
View Market Depth
| Last trade - 10.48am 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |